非藥物憂鬱症治療市場：現況分析與預測（2023-2030）

Drug Free Depression Treatment Market: Current Analysis and Forecast (2023-2030)

出版日期: 2024年02月01日 | 出版商:

UnivDatos Market Insights Pvt Ltd | 英文 145 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

由於憂鬱症患者數量的增加，非藥物憂鬱症治療市場預計將以約10.1%的速度穩定成長。例如，根據世界衛生組織 (WHO) 的統計，估計有 3.8% 的人口患有憂鬱症，其中包括 5% 的成年人（4% 男性和 6% 女性）和 5.7% 的 60 歲以上成年人。過憂鬱症。在預測期內，有幾個因素推動了市場的成長，例如焦慮病例的急劇增加、心理健康意識的提高以及對心理學部門的投資增加。除此之外，透過非藥物憂鬱症治療提高治療效率帶來了有效的治療程序，這也推動了非藥物憂鬱症治療市場的穩定成長。

依治療類型，市場分為認知行為療法、經顱磁刺激、草藥療法等。由於對非藥物憂鬱症治療的需求不斷增加，認知行為治療領域在2022年佔全球非藥物憂鬱症治療市場的最大佔有率。例如，英國皇家精神病學家學院 2022 年 4 月分析的新數據顯示，2021 年英國認知行為治療 (CBT) 的年度預約人數創下了 1,961,096 人的歷史新高。認知行為治療（CBT）是一種心理治療方法，重點在於思想、情緒和行為之間的連結。它旨在幫助個人識別並改變促使其問題的消極思維模式和行為。它通常是結構化的、以目標為導向的，並包括管理症狀和改善整體健康的實用策略。因此，在治療類型中，認知行為治療領域將在2022年佔重要的市場佔有率。

依設施類型，市場分為醫院、專科診所和復健中心。由於憂鬱症患者數量不斷增加，康復中心細分市場在預測期內預計將佔相當大的市場佔有率。例如，根據世界衛生組織 (WHO) 發佈的 2021 年科學概述，全球焦慮和憂鬱的盛行率增加了 25%。復健中心是專門的設施，為從各種健康狀況（包括憂鬱症）中恢復的人們提供結構化的計劃和治療。這些中心提供全面的護理，以滿足每個人的獨特需求。因此，康復中心類別在預測期內預計將在設施類型中表現出較高的複合年增長率。

為了更瞭解非藥物憂鬱症治療的市場介紹，市場為北美（美國、加拿大等北美地區）、歐洲（德國、英國、法國、西班牙、義大利等歐洲國家）地區）和亞洲。太平洋地區（中國、日本、印度和其他亞太地區）和世界其他地區的全球分佈進行分析。由於人們對藥物副作用的認識不斷提高，以及引入創新的非藥物憂鬱症治療方法的投資不斷增加，北美在 2022 年目前的情況下將主導市場。隨著憂鬱症發病率的上升，政府機構在該地區啟動了心理健康意識計畫。例如，加拿大統計局 2023 年 9 月的一份報告發現，過去十年中，15 歲及以上患有重度憂鬱症、躁鬱症和廣泛性焦慮症的加拿大人比例有所增加。因此，從地區來看，2022年北美將佔較大的市場佔有率。

Depression is a common and serious mood disorder that affects a person's feeling, thinking, and other daily activities. It can cause persistent feelings of sadness, hopelessness, and loss of interest in activities once a person enjoyed. Depression can interfere with their ability to function at work, school, or in daily life and can also lead to a variety of physical symptoms such as changes in appetite or sleep patterns, fatigue, and physical aches or pains. Drug-free depression treatment refers to approaches and therapies used to manage depression without the use of medication. People find relief from depression symptoms through alternative therapies such as acupuncture, massage therapy, herbal remedies, or relaxation techniques like progressive muscle relaxation or biofeedback which is leading to the growth of the market. Several other factors, such as rising research & development activities, rising healthcare expenditure, rising regulatory support, and a surge in government collaborations & partnerships are leading drivers of drug free depression treatment globally.

The Drug Free Depression Treatment Market is expected to grow at a steady rate of around 10.1% owing to the rising cases of depression. For instance, according to the World Health Organization, an estimated 3.8% of the population experience depression, including 5% of adults -4% among men and 6% among women, and 5.7% of adults older than 60 years. Several factors, including a surge in the incidence of anxiety cases, increasing awareness regarding mental health, and increased investments in psychology departments are driving the market's growth during the forecast period. Apart from this, accelerated treatment efficiency with drug free depression treatment has resulted in effective treatment procedures which are also driving this market of drug free depression treatment at a steady rate.

Based on the treatment type, the market is segmented into cognitive behavioural therapy, transcranial magnetic stimulation, herbal remedies, and others. The cognitive behavioural therapy segment held the maximum share in the global market of drug free depression treatment in 2022 owing to the rising demand for drug free depression treatment. For instance, in April 2022, new data analyzed by the Royal College of Psychiatrists showed a record number of 1,961,096 annual appointments for those accessing cognitive behavioral therapy (CBT) across England for the year 2021. Cognitive behavioral therapy (CBT) is a psychotherapy approach that focuses on the connections between thoughts, feelings, and behaviors. It aims to help individuals identify and change negative thought patterns and behaviors contributing to their problems. It's often structured, goal-oriented, and involves practical strategies for managing symptoms and improving overall well-being. Thus, among the treatment type, the cognitive behavioural therapy segment held a significant market share in 2022.

Based on facility type, the market is categorized into hospitals, specialized clinics, and rehabilitation centers. The rehabilitation centers segment is expected to hold a significant share of the market in the forecast period owing to the rising cases of depression. For instance, according to a scientific brief released by the World Health Organization (WHO) in the year 2021, the global prevalence of anxiety and depression increased by a massive 25%. Rehabilitation centers are specialized facilities that provide structured programs and therapies to individuals recovering from various health conditions, including depression. These centers offer comprehensive care tailored to meet the unique needs of each individual. Thus, the rehabilitation centers category is expected to witness a higher CAGR amongst facility types during the forecast period.

For a better understanding of the market adoption of drug free depression treatment, the market is analyzed based on its worldwide presence in countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is dominating the market in the current scenario of 2022 due to the rising awareness about the adverse effects of drugs, and the rising number of investments in introducing innovative drug free depression therapies. Government organizations are initiating mental health awareness programs for the sake of the growing rate of depression cases in the region. For instance, according to Statistics Canada's report in September 2023, the percentage of Canadians aged 15 years and older suffering from major depressive episodes, bipolar disorder, and generalized anxiety disorder has increased in the past 10 years. Thus, amongst regions, North America held a significant share of the market in 2022.

Some of the major players operating in the market include McLean Hospital; Great Oaks Recovery Center; Mayo Foundation for Medical Education and Research (MFMER); Fortis Healthcare; Cleveland Clinic; Craig Hospital; Select Medical Corporation; LHC Group, Inc.; Thomas Jefferson University Hospitals; NYU Langone Hospitals.

1. MARKET INTRODUCTION

1.1.Market Definitions
1.2.Main Objective
1.3.Stakeholders
1.4.Limitation

2. RESEARCH METHODOLOGY OR ASSUMPTION

2.1.Research Process of the Drug Free Depression Treatment Market
2.2.Research Methodology of the Drug Free Depression Treatment Market
2.3.Respondent Profile

3. MARKET SYNOPSIS

4. EXECUTIVE SUMMARY

5. IMPACT OF COVID-19 ON THE DRUG FREE DEPRESSION TREATMENT MARKET

6. DRUG FREE DEPRESSION TREATMENT MARKET REVENUE (USD BN), 2020-2030F

7. MARKET INSIGHTS BY TREATMENT TYPE

7.1.Cognitive Behavioural Therapy
7.2.Transcranial Magnetic Stimulation
7.3.Herbal Remedies
7.4.Others

8. MARKET INSIGHTS BY FACILITY TYPE

8.1.Hospitals
8.2.Specialized Clinics
8.3.Rehabilitation Centers

9. MARKET INSIGHTS BY REGION

9.1.North America
- 9.1.1.U.S.
- 9.1.2.Canada
- 9.1.3.Rest of North America
9.2.Europe
- 9.2.1.Germany
- 9.2.2.U.K.
- 9.2.3.France
- 9.2.4.Italy
- 9.2.5.Spain
- 9.2.6.Rest of Europe
9.3.Asia-Pacific
- 9.3.1.China
- 9.3.2.Japan
- 9.3.3.India
- 9.3.4.Rest of Asia-Pacific
9.4.Rest of World